Please use this identifier to cite or link to this item:
|Title:||Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity||Authors:||Pook, S.-H.
|Issue Date:||2006||Citation:||Pook, S.-H., Mahendran, R., Toh, C.-K. (2006). Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity. Cancer Letters 238 (1) : 146-152. ScholarBank@NUS Repository. https://doi.org/10.1016/j.canlet.2005.07.002||Abstract:||The cytotoxic activity of Brostallicin was previously shown to be enhanced in the presence of high glutathione and glutathione transferase levels. We hypothesized that thiol antioxidants, N-acetylcysteine and Silibinin, could potentiate Brostallicin's cytotoxicity in a similar way. HepG2 and CNE-2 cells were treated with N-acetylcysteine, Silibinin and Brostallicin, either alone or in combination. Surprisingly, we found that NAC and Silibinin had adverse effects on Brostallicin's cytotoxicity. The mechanism underlying the interaction involved the apoptotic pathway as we demonstrated an increase in Bcl-2 protein levels and decrease in caspase 3 activity with the Silibinin-Brostallicin combination. © 2005 Elsevier Ireland Ltd. All rights reserved.||Source Title:||Cancer Letters||URI:||http://scholarbank.nus.edu.sg/handle/10635/24056||ISSN:||03043835||DOI:||10.1016/j.canlet.2005.07.002|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Oct 17, 2019
WEB OF SCIENCETM
checked on Oct 10, 2019
checked on Oct 14, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.